MORGAN STANLEY - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$587,915
-33.7%
107,874
-17.4%
0.00%
Q2 2023$886,923
-29.3%
130,622
-47.8%
0.00%
Q1 2023$1,254,750
-12.5%
250,449
-14.8%
0.00%
Q4 2022$1,434,540
-61.1%
293,963
+15.1%
0.00%
-100.0%
Q3 2022$3,684,000
-34.9%
255,492
-31.7%
0.00%0.0%
Q2 2022$5,660,000
-12.0%
374,156
-30.9%
0.00%0.0%
Q1 2022$6,434,000
+36.7%
541,561
+86.5%
0.00%0.0%
Q4 2021$4,706,000
+96.3%
290,384
+245.7%
0.00%
Q3 2021$2,397,000
-23.0%
84,006
-8.9%
0.00%
Q2 2021$3,114,000
-52.0%
92,166
-57.0%
0.00%
-100.0%
Q1 2021$6,484,000
-1.0%
214,436
+62.1%
0.00%0.0%
Q4 2020$6,550,000
+126.3%
132,285
+75.5%
0.00%0.0%
Q3 2020$2,894,000
-18.3%
75,392
-8.0%
0.00%0.0%
Q2 2020$3,541,000
+2484.7%
81,951
+1460.7%
0.00%
Q1 2020$137,000
-98.2%
5,251
-97.9%
0.00%
-100.0%
Q4 2019$7,722,000
+126.2%
247,101
+88.6%
0.00%
+100.0%
Q3 2019$3,414,000
+56800.0%
130,996
+47020.9%
0.00%
Q2 2019$6,000
-83.8%
278
-79.9%
0.00%
Q1 2019$37,000
-83.4%
1,382
-87.4%
0.00%
Q4 2018$223,000
+7333.3%
10,966
+10866.0%
0.00%
Q3 2018$3,0001000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,194,278$108,639,0006.47%
Memorial Sloan Kettering Cancer Center 216,916$10,740,0004.55%
Burrage Capital Management LLC 114,962$5,692,0004.34%
MPM BioImpact LLC 674,582$33,398,0002.88%
First Light Asset Management, LLC 635,652$31,471,0002.33%
Cormorant Asset Management, LP 1,661,647$82,268,0001.96%
ASHFORD CAPITAL MANAGEMENT INC 219,419$10,863,0001.05%
ORACLE INVESTMENT MANAGEMENT INC 126,342$6,255,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 131,016$6,487,0000.58%
Artal Group S.A. 285,028$14,112,0000.30%
View complete list of Y-MABS THERAPEUTICS INC shareholders